<--- Back to Details
First PageDocument Content
American brands / Biotechnology / Pharmaceutical industry / Pharmacy / Pharmaceuticals policy / Catalent / WuXi PharmaTech / Boehringer Ingelheim / Hikma Pharmaceuticals / Laboratoires Servier / Biosimilar / Pfizer
Date: 2016-01-05 08:55:57
American brands
Biotechnology
Pharmaceutical industry
Pharmacy
Pharmaceuticals policy
Catalent
WuXi PharmaTech
Boehringer Ingelheim
Hikma Pharmaceuticals
Laboratoires Servier
Biosimilar
Pfizer

November 20, 2015 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum 1. Merck KGaA Completes $17 Billion Acquisition of Sigma Aldrich Wi

Add to Reading List

Source URL: www.dcat.org

Download Document from Source Website

File Size: 309,91 KB

Share Document on Facebook

Similar Documents

November 20, 2015  BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum 1. Merck KGaA Completes $17 Billion Acquisition of Sigma Aldrich Wi

November 20, 2015 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum 1. Merck KGaA Completes $17 Billion Acquisition of Sigma Aldrich Wi

DocID: 1oQK4 - View Document

Societe SCIENCE UNION et SA LABORATOIRES SERVIER c� LABORATOIRES BIOPHELIA, Societe AJ PHARMA et SA PHARMA DEVELOPPEMENT

Societe SCIENCE UNION et SA LABORATOIRES SERVIER c LABORATOIRES BIOPHELIA, Societe AJ PHARMA et SA PHARMA DEVELOPPEMENT

DocID: VWPr - View Document

Neubeurteilung des Nutzen/Risikos von Procoralan (Suresnes), den 8. Mai 2014 – Die Laboratoires Servier melden, dass die European Medecines Agency (EMA) eine Neubeurteilung des Nutzen/Risikos von Procoralan (Ivabradin)

Neubeurteilung des Nutzen/Risikos von Procoralan (Suresnes), den 8. Mai 2014 – Die Laboratoires Servier melden, dass die European Medecines Agency (EMA) eine Neubeurteilung des Nutzen/Risikos von Procoralan (Ivabradin)

DocID: QvBY - View Document

Communiqué de presse Paris, le 15 février 2011 Mediator® La MSA et le RSI portent plainte pour escroquerie et tromperie aggravée contre les laboratoires Servier

Communiqué de presse Paris, le 15 février 2011 Mediator® La MSA et le RSI portent plainte pour escroquerie et tromperie aggravée contre les laboratoires Servier

DocID: dA8v - View Document